tyrosine has been researched along with Chronic Hepatitis C in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aizawa, N; Enomoto, H; Hasegawa, K; Iijima, H; Ikeda, N; Ishii, A; Ishii, N; Iwata, Y; Miyamoto, Y; Nakano, C; Nishiguchi, S; Nishikawa, H; Nishimura, T; Sakai, Y; Takashima, T; Takata, R; Yoh, K; Yuri, Y | 1 |
Inoue, J; Iwata, T; Kakazu, E; Kogure, T; Morosawa, T; Nakamura, T; Ninomiya, M; Sano, A; Shimosegawa, T; Takai, S; Umetsu, T | 1 |
Brigandi, R; Chuang, WL; Gardner, S; Goodman, Z; Husa, P; Jonas, M; Levine, R; Makhlouf, H; McHutchison, J; Patel, K; Rockey, D; Rodriguez-Torres, M; Schultz, M; Shiffman, M; Stancil, B; Theodore, D; Watson, H; Webster, A | 1 |
Krupińska, J; Pobłocki, J; Syrenicz, A; Urbanowicz, W; Wawrzynowicz-Syczewska, M | 1 |
Bezemer, G; de Knegt, RJ; Fekkes, D; Hansen, BE; Janssen, HL; Van Gool, AR; Vrolijk, JM | 1 |
Caputi, AP; Cuzzocrea, S; Longo, G; Villari, D; Zingarelli, B | 1 |
Hayashi, Y; Kasuga, M; Kumon, Y; Nagano, H; Ninomiya, T; Seo, Y; Shimizu, K; Sugano, M; Yoon, S | 1 |
Apolinario, A; García-Monzón, C; Majano, PL; Moreno-Otero, R; Sanz, P; Zubia, I | 1 |
De Bie, S; De Paepe, A; De Vos, M; Delanghe, JR; Leroux-Roels, G; Messiaen, L; Praet, M; Van Vlierberghe, H | 1 |
Hayashi, H; Ikeda, R; Imaizumi, Y; Kawanaka, M; Sanae, F; Shiono, Y; Takikawa, T; Wakusawa, S; Yamada, G; Yano, M; Yoshioka, K | 1 |
1 trial(s) available for tyrosine and Chronic Hepatitis C
Article | Year |
---|---|
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection.
Topics: Adult; Aged; Biopsy; Double-Blind Method; Female; Hepatitis C, Chronic; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Oxazoles; PPAR gamma; Tyrosine | 2010 |
9 other study(ies) available for tyrosine and Chronic Hepatitis C
Article | Year |
---|---|
Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids, Branched-Chain; Antiviral Agents; Biomarkers; Body Composition; Electric Impedance; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hyaluronic Acid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Muscle, Skeletal; Retrospective Studies; Sustained Virologic Response; Time Factors; Treatment Outcome; Tyrosine; Viral Load | 2017 |
The profiling of plasma free amino acids and the relationship between serum albumin and plasma-branched chain amino acids in chronic liver disease: a single-center retrospective study.
Topics: Adult; Aged; Amino Acids, Branched-Chain; Chronic Disease; Disease Progression; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Serum Albumin; Severity of Illness Index; Tyrosine | 2018 |
The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Autoimmunity; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Thyroglobulin; Thyroid Gland; Thyroiditis, Autoimmune; Thyrotropin; Time Factors; Triiodothyronine; Tyrosine; Young Adult | 2011 |
Psychiatric side effects and fluctuations in serotonergic parameters in the treatment of chronic hepatitis C infection.
Topics: Adult; Antiviral Agents; Chromatography, High Pressure Liquid; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Mood Disorders; Neopterin; Phenylalanine; Polyethylene Glycols; Prolactin; Psychometrics; Recombinant Proteins; Serotonin; Statistics, Nonparametric; Time Factors; Tyrosine | 2012 |
Evidence for in vivo peroxynitrite production in human chronic hepatitis.
Topics: Adult; Antibodies; Antibody Specificity; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunohistochemistry; Liver Cirrhosis; Male; Middle Aged; Nitrates; Tyrosine | 1998 |
Improvement of molar ratio of branched-chain amino acids to tyrosine (BTR) associated with liver fibrosis in chronic hepatitis C patients treated with interferon-alpha.
Topics: Adult; Aged; Amino Acids, Branched-Chain; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Tyrosine | 1999 |
Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease.
Topics: Adult; Female; Hepatitis; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunologic Techniques; Liver; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Severity of Illness Index; Tissue Distribution; Tyrosine | 2000 |
Association between Cys282Tyr missense mutation and haptoglobin phenotype polymorphism in patients with chronic hepatitis C.
Topics: Adult; Aged; Alleles; Case-Control Studies; Chi-Square Distribution; Cohort Studies; Cysteine; Female; Genetic Predisposition to Disease; Genetic Testing; Haptoglobins; Hepatitis C, Chronic; Humans; Male; Middle Aged; Mutation, Missense; Phenotype; Polymorphism, Genetic; Prevalence; Probability; Reference Values; Risk Assessment; Tyrosine | 2001 |
C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.
Topics: Adult; Asian People; Aspartic Acid; Cysteine; Female; Hemochromatosis; Hemochromatosis Protein; Hepatitis C, Chronic; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Iron Overload; Japan; Liver Diseases; Male; Membrane Proteins; Middle Aged; Point Mutation; Polymerase Chain Reaction; Tyrosine | 2001 |